A new class of drug developed at Northwestern University Feinberg School of Medicine shows early promise of being a one-size-fits-all therapy for Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic brain injury by reducing...
Read more:
http://medicalxpress.com/news/2012-07-drug-alzheimer-multiple-sclerosis-brain.html